99 related articles for article (PubMed ID: 21626781)
21. Carrageenans inhibit growth-factor binding.
Hoffman R
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):331-4. PubMed ID: 8424778
[TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effects of ampelopsin on angiogenesis].
Luo GQ; Zeng S; Liu DY
Zhong Yao Cai; 2006 Feb; 29(2):146-50. PubMed ID: 16617784
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo.
Peng CY; Pan SL; Lee KH; Bastow KF; Teng CM
Cancer Lett; 2008 May; 263(1):114-21. PubMed ID: 18243528
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides.
Yuan H; Song J; Li X; Li N; Dai J
Cancer Lett; 2006 Nov; 243(2):228-34. PubMed ID: 16410037
[TBL] [Abstract][Full Text] [Related]
25. Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide.
Tan H; Chen H; Xu C; Ge Z; Gao Y; Fang J; Liu W; Xiao S
J Gastroenterol Hepatol; 2012 Jun; 27(6):1094-101. PubMed ID: 22098296
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.
Johnstone KD; Karoli T; Liu L; Dredge K; Copeman E; Li CP; Davis K; Hammond E; Bytheway I; Kostewicz E; Chiu FC; Shackleford DM; Charman SA; Charman WN; Harenberg J; Gonda TJ; Ferro V
J Med Chem; 2010 Feb; 53(4):1686-99. PubMed ID: 20128596
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
[TBL] [Abstract][Full Text] [Related]
30. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88.
Fairweather JK; Hammond E; Johnstone KD; Ferro V
Bioorg Med Chem; 2008 Jan; 16(2):699-709. PubMed ID: 17967543
[TBL] [Abstract][Full Text] [Related]
32. Identification of polyoxometalates as inhibitors of basic fibroblast growth factor.
Pu F; Wang E; Jiang H; Ren J
Mol Biosyst; 2013 Jan; 9(1):113-20. PubMed ID: 23123725
[TBL] [Abstract][Full Text] [Related]
33. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
34. Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.
Zhen HY; Huang YH; Zhen YS
Yao Xue Xue Bao; 2005 Dec; 40(12):1110-5. PubMed ID: 16496675
[TBL] [Abstract][Full Text] [Related]
35. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
Tumova S; Hatch BA; Law DJ; Bame KJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of a bacteria-derived sulfated polysaccharide against basic fibroblast growth factor-induced endothelial cell growth and chemotaxis.
Nakayama Y; Iwahana M; Sakamoto N; Tanaka NG; Osada Y
J Cell Physiol; 1993 Jan; 154(1):1-6. PubMed ID: 8419396
[TBL] [Abstract][Full Text] [Related]
37. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.
Ishai-Michaeli R; Eldor A; Vlodavsky I
Cell Regul; 1990 Oct; 1(11):833-42. PubMed ID: 2088528
[TBL] [Abstract][Full Text] [Related]
38. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.
Reis RC; Schuppan D; Barreto AC; Bauer M; Bork JP; Hassler G; Coelho-Sampaio T
Biochem Biophys Res Commun; 2005 Aug; 333(3):976-83. PubMed ID: 15985216
[TBL] [Abstract][Full Text] [Related]
39. Carrageenan delays cell cycle progression in human cancer cells in vitro demonstrated by FUCCI imaging.
Prasedya ES; Miyake M; Kobayashi D; Hazama A
BMC Complement Altern Med; 2016 Aug; 16():270. PubMed ID: 27487950
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity.
Benezra M; Ishai-Michaeli R; Ben-Sasson SA; Vlodavsky I
J Cell Physiol; 2002 Sep; 192(3):276-85. PubMed ID: 12124773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
